Folates as adjuvants to anticancer agents: Chemical rationale and mechanism of action

Peter V. Danenberg; Bengt Gustavsson; Patrick Johnston; Per Lindberg; Rudolf Moser; Elisabeth Odin; Godefridus J. Peters; Nicholas Petrelli

doi:10.1016/j.critrevonc.2016.08.001

Folates as adjuvants to anticancer agents: Chemical rationale and mechanism of action

Peter V. Danenberg, Bengt Gustavsson, Patrick Johnston, Per Lindberg, Rudolf Moser, Elisabeth Odin, Godefridus J. Peters, Nicholas Petrelli

Medical oncology laboratory

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	118-131
Journal	Critical Reviews in Oncology / Hematology
Volume	106
DOIs	https://doi.org/10.1016/j.critrevonc.2016.08.001
Publication status	Published - Oct 2016

Access to Document

10.1016/j.critrevonc.2016.08.001

Cite this

@article{d05f35cf0f384a95b92ba15a75d656ef,

title = "Folates as adjuvants to anticancer agents: Chemical rationale and mechanism of action",

keywords = "Folate metabolism, Leucovorin, Mechanism of action, 5-Fluorouracil, [6R]-5,10-methylene-tetrahydrofolate",

author = "Danenberg, {Peter V.} and Bengt Gustavsson and Patrick Johnston and Per Lindberg and Rudolf Moser and Elisabeth Odin and Peters, {Godefridus J.} and Nicholas Petrelli",

year = "2016",

month = oct,

doi = "10.1016/j.critrevonc.2016.08.001",

language = "English",

volume = "106",

pages = "118--131",

journal = "Critical Reviews in Oncology / Hematology",

issn = "1040-8428",

publisher = "Elsevier Ireland Ltd",

}

TY - JOUR

T1 - Folates as adjuvants to anticancer agents: Chemical rationale and mechanism of action

AU - Danenberg, Peter V.

AU - Gustavsson, Bengt

AU - Johnston, Patrick

AU - Lindberg, Per

AU - Moser, Rudolf

AU - Odin, Elisabeth

AU - Peters, Godefridus J.

AU - Petrelli, Nicholas

PY - 2016/10

Y1 - 2016/10

KW - Folate metabolism

KW - Leucovorin

KW - Mechanism of action

KW - 5-Fluorouracil, [6R]-5,10-methylene-tetrahydrofolate

U2 - 10.1016/j.critrevonc.2016.08.001

DO - 10.1016/j.critrevonc.2016.08.001

M3 - Article

C2 - 27637357

VL - 106

SP - 118

EP - 131

JO - Critical Reviews in Oncology / Hematology

JF - Critical Reviews in Oncology / Hematology

SN - 1040-8428

ER -